5 results about "Silencing gene" patented technology

Provided herein are compositions, systems, and methods for the creation, identification, and characterization of effector domains for activating and silencing gene expression. In particular, a high-throughput system for discovering and characterizing effector domains is provided.

This invention discloses NtBRL2 The application of genes in regulating potassium content in plants belongs to the field of plant genetic engineering technology. This invention provides a gene that can effectively regulate potassium content in plant leaves, a feature of existing technologies. NtBRL2 This invention first discovered through Real-time PCR. NtBRL2 The gene was expressed at the highest level in tobacco roots; then, a silenced gene was constructed using virus-induced gene silencing (VIGS) technology. NtBRL2 The VIGS vector of the gene was transformed into Nicotiana benthamiana, and repression was successfully achieved. NtBRL2 Silent plants, obtained by silencing gene expression, exhibit a specific phenotype with significantly lower potassium ion content compared to control plants, indicating that silencing this gene can significantly reduce potassium ion content in plants. This invention lays the foundation for elucidating the biological regulation mechanism of potassium ions and provides precise regulatory sites for the regulation of potassium ion content in plants.

This invention discloses an engineered bacterium producing tetracrine, its construction, and its application. The invention utilizes a strong promoter to drive the high expression of regulatory genes ovmZn and ovmWn in *Streptomyces neyagawa*, constructing a recombinant engineered strain Sne / pZWn; alternatively, it utilizes a strong promoter to drive the high expression of homologous genes of both, including the regulatory genes ovmZ and ovmW from *Streptomyces chromogenicus*, in *Streptomyces neyagawa*, constructing a recombinant engineered strain Sne / pZW. These engineered strains can express previously silenced gene clusters, activating tetracrine biosynthesis and laying the foundation for the development and application of tetracrine.

The present application belongs to the field of biotechnology, and specifically relates to a method for high-throughput screening of nucleic acid drug target genes, which comprises the following steps: treating cells with nucleic acid drug candidates or negative controls, and collecting measurement values for a plurality of cell characteristic parameters related to the treatment purpose of the nucleic acid drug; calculating the fold change of the characteristic parameter measurement values of the cells in each candidate hole relative to the negative control measurement values and normalizing them; for all measurement values, calculating the squared Mahalanobis distance of the plurality of cell characteristic parameters relative to the average value using the normalized values; screening out the candidates with squared Mahalanobis distance greater than a cutoff value, and unsupervised clustering the cells according to the plurality of cell characteristic parameters to divide the candidates into at least one cluster; obtaining the corresponding silenced genes of the candidates in each cluster, and performing gene ontology enrichment analysis on the genes in the cluster to obtain the biological processes associated with each cluster, and finally obtaining nucleic acid drug target genes for different biological processes.